This project aims at investigating the genetic, genomic and proteomic basis of hypertension and susceptibility to hypertension-related end organ damage (renal damage and heart failure). It will include cross sectional as well as follow-up studies with a large number of subjects and variety of phenotypes, to explore the pathophysiology of hypertension and hypertension-related disease.
In all index patients and recruited family members, recorded data will include the following : * Past medical history, drug history and family history * Physical examination * Height, weight, waist and hip circumference * Cardiac examination * Vascular examination * Blood pressure * Plasma and urine samples * Body composition (DEXA) * Tissue Doppler imaging
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
60
blood and urine sample
Centre D'Investigation Clinique de Strasbourg
Strasbourg, Alsace, France
Hopital Brabois adulte
Nancy, Lorraine, France
genetic biomarkers
Time frame: time point 1 : first day ; Time point
oxidative stress markers
Time frame: time point 1 : first day ; Time point 2 : 2 years ; Time point 3 : 4 years
microinflammation markers
Time frame: time point 1 : first day ; Time point 2 : 2 years ; Time point 3 : 4 years
renal function and damage markers
Time frame: time point 1 : first day ; Time point 2 : 2 years ; Time point 3 : 4 years
cardiac and large artery growth, remodelling dysfunction and failure markers
Time frame: time point 1 : first day ; Time point 2 : 2 years ; Time point 3 : 4 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.